ATS Stat

HomeATS Stat ▶ Stat Oct. 14, 2020
Stat Oct. 14, 2020

Join Us! Assembly Symposia

ATS Assemblies are offering virtual mini-symposia this fall. Join us for 90-minute sessions discussing:

  • Newman Stephens Memorial Session: A Legacy of Science and Success

When: TODAY, 6 p.m. ET, Oct. 14, 2020

  • Late Breaking Clinical Trials in Airway Diseases

When: 10 a.m. ET, Oct. 16, 2020

  • Novel Causes of Environmental Asthma

When: 5 p.m. ET, Oct. 19, 2020

  • What's New in Clinical and Translational Research In Pulmonary Hypertension: Lessons from the Best Abstracts

When: 12 p.m. ET, Oct. 21, 2020

  • Phenotypes, Endotypes, and Novel Therapies for SDB

When: 4 p.m. ET, Oct. 26, 2020

  • Machine Learning and Data Driven Health Care Delivery

When: 4 p.m. ET, Oct. 27, 2020

  • Tuberculosis Science Highlights

When: 2 p.m. ET, Oct. 28, 2020

  • Expanding Our Horizons: Leading Research in Pulmonary Rehabilitation 2020

When: 10 a.m. ET, Nov. 2, 2020

Learn more about the full program!


ATS PAR Abstract Scholarship Presentations

Due to the cancellation of ATS 2020, this year’s ATS Public Advisory Roundtable activities were held virtually. Awardees presented a two-to-three minute overview of their science after a welcome by ATS Secretary-Treasurer M. Patricia Rivera, MD, ATSF; PAR chair-elect Michele Manion; and ATS Assembly leadership Jay Kolls, MD, and MeiLan Han, MD, MS. 

Watch now!


Upcoming Events

Industry Innovations Webinars
Join us for “A Path to Asthma Control: DUPIXENT® (dupilumab) Is the Only Biologic Indicated for OCS-Dependent Asthma.”

When: 6:30 p.m. ET, Oct. 15, 2020
Register now!

Sponsored by Regeneron Sanofi Genzyme.


Join “The Role of Eosinophils and Their Potential Heterogeneity in Airway Disease.”

When: 6:30 ET, Oct. 29, 2020
Register now!

Sponsored by GSK.

By registering for Industry Innovations webinars, you agree to share your information with the sponsor.


CME Opportunity!

Learn what’s new in nontuberculous mycobacterial lung disease from a panel of experts. Download slides, and complete the video modules to earn Continuing Medical Education credits. Full CME information is available on the site.


Twitter Chat

Join Bram Rochwerg, MD (@Bram_Rochwerg)  and Jeremy E. Orr, MD   (@jeremyeorr) to chat about “Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease."  

When: 1 p.m. ET, Oct. 21, 2020 
Where: Twitter, using #ATSchat


Lack of Knowledge Is One Barrier to Prone Positioning in Severe ARDS Caused by COVID-19

A new study published online in the Annals of the American Thoracic Society examines ways to increase the use of prone positioning for patients with severe acute respiratory distress syndrome (ARDS), and develops specific implementation strategies that can assist in clinicians’ response to the COVID-19 pandemic. Prone positioning has been shown to reduce mortality related to severe ARDS, yet most patients with ARDS—up to 85 percent—do not receive this lifesaving therapy.

In “Improving Prone Positioning for Severe ARDS during the COVID-19 Pandemic: An Implementation Mapping Approach,” Meeta Prasad Kerlin, MD, MSCE, an associate professor of medicine in the Perelman School of Medicine at the University of Pennsylvania, and co-authors conducted a multifaceted study to help determine why prone positioning is rarely used as an initial therapeutic strategy for patients with ARDS, as well as ways to address these potential barriers.

Read the full press release.


New Patient Information Resources

View and print the new Patient Information Resource, “COVID-19 Infection versus Influenza (Flu) and Other Respiratory Illnesses” to help your patients navigate flu season amid the COVID-19 pandemic. The ATS has also recently created a new section devoted to oxygen therapy, and our ICU guide for patients and families, “Managing the Intensive Care Unit Experience,” is now available in three languages, and in an audio version.